Thu, Nov 27, 2014, 7:13 AM EST - U.S. Markets closed for Thanksgiving Day


% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • mattgrable268 Jul 3, 2013 2:53 PM Flag

    Old phase II OGX-011 trial question

    Im new to the stock and doing my research on custirsen, I'm looking at the phase 2 trial in Journal of Clinical Oncology from 2010, looking at the baseline predicted 24-month survival rate they list a median 25.6%, with 95% confidence interval 20.4 to 31.0% for treatment arm baseline, compared to 19.6% median with 95% CI of 19.0 to 29.4% for placebo.

    My question is whether the median for the placebo group is correct? I haven't seen a case where the median could be so far towards one end of the 95% confidence interval, typically it would be pretty near the middle as it was in the treatment arm. Anyone better at stats than me that can provide some insight?

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.11+0.02(+0.96%)Nov 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.